Xeris Biopharma Holdings
XERS
XERS
229 hedge funds and large institutions have $789M invested in Xeris Biopharma Holdings in 2025 Q3 according to their latest regulatory filings, with 59 funds opening new positions, 76 increasing their positions, 61 reducing their positions, and 28 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
15% more funds holding
Funds holding: 199 → 229 (+30)
2.14% more ownership
Funds ownership: 57.85% → 59.99% (+2.1%)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
Holders
229
Holding in Top 10
2
Calls
$3.88M
Puts
$782K
Top Buyers
| 1 | +$13.3M | |
| 2 | +$10.3M | |
| 3 | +$5.86M | |
| 4 |
Charles Schwab
San Francisco,
California
|
+$5.84M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$5.52M |
Top Sellers
| 1 | -$16M | |
| 2 | -$5.95M | |
| 3 | -$4.11M | |
| 4 |
Goldman Sachs
New York
|
-$3.16M |
| 5 |
Legal & General Group
London,
United Kingdom
|
-$2.97M |
